These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2334451)

  • 1. Xanthone 1,4-dihydropyridine derivatives with a potent selective bradycardic effect.
    Valenti P; Chiarini A; Gasperi F; Budriesi R
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):122-5. PubMed ID: 2334451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative inotropic and chronotropic activity of calcium channel ligands possessing a xanthone 1,4-dihydropyridine backbone.
    Chiarini A; Rampa A; Bisi A; Budriesi R; Valenti P
    Arzneimittelforschung; 1992 Jun; 42(6):797-801. PubMed ID: 1329778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
    Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
    Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
    Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring.
    Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
    Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
    Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
    Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
    Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coumarin 1,4-dihydropyridine derivatives.
    Valenti P; Rampa A; Budriesi R; Bisi A; Chiarini A
    Bioorg Med Chem; 1998 Jun; 6(6):803-10. PubMed ID: 9681146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological characterization of some benzazepinone derivatives.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.
    Arrowsmith JE; Campbell SF; Cross PE; Burges RA; Gardiner DG
    J Med Chem; 1989 Mar; 32(3):562-8. PubMed ID: 2918502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
    Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
    Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,4-Dihydropyridines bearing a pharmacophoric fragment of lidoflazine.
    Chiarini A; Rampa A; Budriesi R; Bisi A; Fabbri G; Valenti P
    Bioorg Med Chem; 1996 Oct; 4(10):1629-35. PubMed ID: 8931932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
    Budriesi R; Ioan P; Locatelli A; Cosconati S; Leoni A; Ugenti MP; Andreani A; Di Toro R; Bedini A; Spampinato S; Marinelli L; Novellino E; Chiarini A
    J Med Chem; 2008 Mar; 51(6):1592-600. PubMed ID: 18303827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
    Bellucci C; Gualtieri F; Scapecchi S; Teodori E; Budriesi R; Chiarini A
    Farmaco; 1989 Dec; 44(12):1167-91. PubMed ID: 2634406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel halogenated dihydropyridine derivatives with high vascular selectivity.
    Fricke U; Klaus W; Stein B
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):449-54. PubMed ID: 3244387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
    Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
    Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.